ZUJ-26842-16596
3 vaccinations
3 coded responses
27 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 981 / WA
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Pfizer-BioNTech
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-12
- 2021-03-19
-
2021-03-26
Dose 2 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-02
-
2021-04-09
Survey response — day 14, dose 2MedDRA: Fatigue, Headache, Nasal congestion — Feeling: FairFree text: Congestion, headache, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-08
- 2021-06-25
- 2021-09-24
-
2022-01-07
Dose 3 — Pfizer-BioNTech
- 2022-03-26
- 2022-07-09
-
2023-01-07
Survey response — 12 months, dose 3MedDRA: Postpartum disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-01-07
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-01-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2022-01-07 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-07 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 7 — day 14, dose 2
Symptoms: Congestion, headache, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Postpartum disorder | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release